Lv21
108 积分 2022-01-25 加入
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
4小时前
已完结
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
5小时前
已完结
A Radiation‐Activated and Self‐Cascade Nano‐Immunostimulator Triggers a Potent Abscopal Effect Against Distant Tumors
2个月前
已完结
When will the immune-stimulating antibody conjugates (ISACs) be transferred from bench to bedside?
2个月前
已完结
Precision Chemoradiotherapy via EGFR Targeting with Radiotherapy-Activated Drug Conjugates
2个月前
已完结
Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions
3个月前
已完结
Nanobody-based drug delivery systems for cancer therapy
4个月前
已完结
Trends in nanobody radiotheranostics
4个月前
已完结
Management of nausea and vomiting (N/V) following first-line (1L) zolbetuximab + chemotherapy treatment in claudin-18.2 (CLDN18.2)+, HER2−, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Analysis from the phase 3 SPOTLIGHT and GLOW studies
5个月前
已完结
Dual-payload ADCs move into first oncology clinical trials
6个月前
已完结
皖公网安备34019202002308
